Strategy — MicroStrategy until it renamed itself in early 2025 — spent six years as the purest expression of a single idea: borrow against your equity, buy bitcoin, repeat. In 2026 that idea met its first real test, and the mechanism that made it work turned out to run in both directions.
How the flywheel worked
The number that governs everything here is mNAV: the multiple of net asset value the market assigns the stock. When Strategy traded at 1.8× the value of its bitcoin, the company could issue shares at that premium, buy bitcoin with the proceeds, and end up with more bitcoin per existing share than before. Shareholders got richer without the bitcoin price moving at all.
That flywheel is genuinely clever and it is not a trick. It works precisely as long as the premium exists.
On 27 June 2026, Strategy's enterprise mNAV fell below 1.0 for the first time. The market began valuing the company at less than the bitcoin sitting on its balance sheet.
At a discount, the flywheel reverses. Issuing shares to buy bitcoin now destroys bitcoin per share rather than creating it. The single mechanism that funded six years of accumulation stops being available at exactly the moment it would be most useful.
Where it stands
| Bitcoin held | 843,775 BTC |
| Average cost per bitcoin | ~$75,476 |
| Bitcoin price | ~$62,855 |
| Share price | $93.04 |
| 52-week range | $81.81 – $372.62 |
| Annual preferred dividends | >$1.5bn |
The treasury is underwater. Bitcoin at roughly $63,000 against a cost basis near $75,476 means the accumulated position is showing an unrealised loss — the first sustained period in which the strategy has been wrong on its own terms. The share price has fallen roughly 75% from its 52-week high.
The dividend problem
Here is the bind. Strategy funded much of its buying through preferred stock, which carries dividend obligations exceeding $1.5bn a year. Those are cash commitments. Bitcoin does not pay a coupon, and the software business does not cover the gap.
With the equity premium gone, the cash has to come from somewhere. In May the company reported selling 32 bitcoin — trivial in size, enormous in signal, because it had never sold any. By early July it had sold 3,588 bitcoin for roughly $216m under a formalised BTC Monetization Programme.
Management wrapped this in a Digital Credit Capital Framework: a $2.55bn dollar reserve, authorisation for up to $1bn of buybacks, and permission to monetise up to 20,800 bitcoin — about 2.5% of holdings — to cover dividends and debt service. The framework is meant to reassure creditors. It also confirms what the market had already priced: selling bitcoin is now a normal tool rather than an unthinkable last resort.
What this actually is now
MSTR remains the most direct listed proxy for corporate bitcoin exposure, and that has real value for investors who cannot hold the asset directly. But it is not a bitcoin tracker, and 2026 made the difference concrete.
You are buying three things at once: bitcoin, leverage on bitcoin, and a capital structure with fixed obligations that must be serviced regardless of price. The third is what makes the stock fall further than bitcoin on down days — on 25 June it dropped 8.55% while bitcoin fell under 5%. That is mNAV compression, and it is a sentiment gauge wearing a valuation costume.
The lesson beyond one company
Dozens of companies copied this playbook. Every one of them depends on the same premium mechanism, and most have shorter track records, worse cost bases and thinner access to capital than Strategy does.
If the pioneer — with the largest holdings, the most established credit relationships and Michael Saylor's considerable powers of persuasion — trades below the value of its own bitcoin, the copies are underwriting a bet with no margin for error. The treasury-company trade was always a leveraged bet on the premium persisting, not on bitcoin itself. That distinction was easy to miss on the way up.
Share price and 52-week range from Yahoo Finance, bitcoin price from CoinGecko, both on 14 August 2026. Holdings, cost basis, sales and capital framework details from company 8-K filings and public reporting. Nothing here is a recommendation or investment advice — MSTR is a highly volatile equity and we are not authorised to advise on it.